Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. A systematic review and meta-analysis.

Delluc A, Miranda S, den Exter P, Louzada M, Alatri A, Ahn S, Monreal M, Khorana A, Huisman MV, Wells PS, Carrier M.

Haematologica. 2019 Jul 4. pii: haematol.2019.222828. doi: 10.3324/haematol.2019.222828. [Epub ahead of print]

2.

Direct oral anticoagulants and obesity: one size fits all?

den Exter PL, Huisman MV.

Lancet Haematol. 2019 Jul;6(7):e341-e342. doi: 10.1016/S2352-3026(19)30092-4. Epub 2019 May 24. No abstract available.

PMID:
31133410
3.

Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm.

van der Pol LM, Bistervels IM, van Mens TE, van der Hulle T, Beenen LFM, den Exter PL, Kroft LJM, Mairuhu ATA, Middeldorp S, van Werkhoven JM, Ten Wolde M, Huisman MV, Klok FA.

Br J Haematol. 2018 Nov;183(4):629-635. doi: 10.1111/bjh.15556. Epub 2018 Sep 10.

4.

The YEARS algorithm for suspected pulmonary embolism: shorter visit time and reduced costs at the emergency department.

van der Pol LM, Dronkers CEA, van der Hulle T, den Exter PL, Tromeur C, Heringhaus C, Mairuhu ATA, Huisman MV, van den Hout WB, Klok FA.

J Thromb Haemost. 2018 Apr;16(4):725-733. doi: 10.1111/jth.13972. Epub 2018 Mar 13.

PMID:
29431911
5.

Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.

den Exter PL, Hooijer J, van der Hulle T, van Oosten JP, Dekkers OM, Klok FA, Huisman MV.

Thromb Haemost. 2017 Nov 1;117(11):2163-2167. doi: 10.1160/TH-17-06-0382. Epub 2017 Oct 4.

PMID:
28981552
6.

Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.

van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, Douma RA, Kruip MJHA, Hovens MMC, Ten Wolde M, Nijkeuter M, Ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok FA.

Thromb Haemost. 2017 Jul 26;117(8):1622-1629. doi: 10.1160/TH17-02-0076. Epub 2017 Jun 1.

PMID:
28569924
7.

Reply: N-Terminal Pro-Brain Natriuretic Peptide Trial Design.

den Exter PL, Klok FA, Huisman MV.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):531-532. doi: 10.1164/rccm.201701-0252LE. No abstract available.

PMID:
28252319
8.

Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.

Wilts IT, Le Gal G, Den Exter PL, Van Es J, Carrier M, Planquette B, Büller HR, Righini M, Huisman MV, Kamphuisen PW.

Thromb Res. 2017 Apr;152:49-51. doi: 10.1016/j.thromres.2017.02.007. Epub 2017 Feb 13.

PMID:
28226257
9.

The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis.

van Es N, Kraaijpoel N, Klok FA, Huisman MV, Den Exter PL, Mos IC, Galipienzo J, Büller HR, Bossuyt PM.

J Thromb Haemost. 2017 Apr;15(4):678-684. doi: 10.1111/jth.13630. Epub 2017 Feb 16.

10.

Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.

van der Wall SJ, Klok FA, den Exter PL, Barrios D, Morillo R, Cannegieter SC, Jimenez D, Huisman MV.

J Thromb Haemost. 2017 Jan;15(1):74-79. doi: 10.1111/jth.13563. Epub 2016 Dec 24.

11.

Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis.

van Es N, van der Hulle T, van Es J, den Exter PL, Douma RA, Goekoop RJ, Mos IC, Galipienzo J, Kamphuisen PW, Huisman MV, Klok FA, Büller HR, Bossuyt PM.

Ann Intern Med. 2016 Aug 16;165(4):253-61. doi: 10.7326/M16-0031. Epub 2016 May 17. Review.

PMID:
27182696
12.

PO-29 - Age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy.

Wilts IT, Le Gal G, den Exter PL, van Es J, Carrier M, Planquette B, Büller HR, Righini M, Huisman MV, Kamphuisen PW.

Thromb Res. 2016 Apr;140 Suppl 1:S187. doi: 10.1016/S0049-3848(16)30162-1. Epub 2016 Apr 8.

PMID:
27161718
13.

PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis.

van Es N, van der Hulle T, van Es J, den Exter PL, Douma RA, Goekoop RJ, Mos IC, Garcia JG, Kamphuisen PW, Huisman MV, Klok FA, Büller HR, Bossuyt PM.

Thromb Res. 2016 Apr;140 Suppl 1:S179. doi: 10.1016/S0049-3848(16)30140-2. Epub 2016 Apr 8.

PMID:
27161697
14.

Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.

den Exter PL, Zondag W, Klok FA, Brouwer RE, Dolsma J, Eijsvogel M, Faber LM, van Gerwen M, Grootenboers MJ, Heller-Baan R, Hovens MM, Jonkers GJ, van Kralingen KW, Melissant CF, Peltenburg H, Post JP, van de Ree MA, Vlasveld LT, de Vreede MJ, Huisman MV; Vesta Study Investigators *.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):998-1006.

PMID:
27030891
15.

Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer.

van der Hulle T, den Exter PL, van den Hoven P, van der Hoeven JJ, van der Meer FJ, Eikenboom J, Huisman MV, Klok FA.

Chest. 2016 May;149(5):1245-51. doi: 10.1016/j.chest.2015.10.069. Epub 2016 Jan 13.

PMID:
26836911
16.

Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients.

van der Hulle T, den Exter PL, Planquette B, Meyer G, Soler S, Monreal M, Jiménez D, Portillo AK, O'Connell C, Liebman HA, Shteinberg M, Adir Y, Tiseo M, Bersanelli M, Abdel-Razeq HN, Mansour AH, Donnelly OG, Radhakrishna G, Ramasamy S, Bozas G, Maraveyas A, Shinagare AB, Hatabu H, Nishino M, Huisman MV, Klok FA.

J Thromb Haemost. 2016 Jan;14(1):105-13. doi: 10.1111/jth.13172. Epub 2016 Jan 11.

17.

Reliability of diagnosing incidental pulmonary embolism in cancer patients.

den Exter PL, van der Hulle T, Hartmann IJ, Jiménez D, Klok FA, Huisman MV, Kroft LJ.

Thromb Res. 2015 Sep;136(3):531-4. doi: 10.1016/j.thromres.2015.06.027. Epub 2015 Jun 19.

PMID:
26254194
18.

Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism.

den Exter PL, van Es J, Kroft LJ, Erkens PM, Douma RA, Mos IC, Jonkers G, Hovens MM, Durian MF, ten Cate H, Beenen LF, Kamphuisen PW, Huisman MV; Prometheus Follow-Up Investigators.

Thromb Haemost. 2015 Jul;114(1):26-34. doi: 10.1160/TH14-10-0842. Epub 2015 May 28.

PMID:
26017397
19.

A simple decision rule including D-dimer to reduce the need for computed tomography scanning in patients with suspected pulmonary embolism.

van Es J, Beenen LF, Douma RA, den Exter PL, Mos IC, Kaasjager HA, Huisman MV, Kamphuisen PW, Middeldorp S, Bossuyt PM.

J Thromb Haemost. 2015 Aug;13(8):1428-35. doi: 10.1111/jth.13011. Epub 2015 Jun 19.

20.

Computerised clinical decision support for suspected PE.

Jiménez D, Resano S, Otero R, Jurkojc C, Portillo AK, Ruiz-Artacho P, Corres J, Vicente A, den Exter PL, Huisman MV, Moores L, Yusen RD; IRYCIS Pulmonary Embolism Study Group.

Thorax. 2015 Sep;70(9):909-11. doi: 10.1136/thoraxjnl-2014-206689. Epub 2015 Feb 9.

PMID:
25666436
21.

Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.

Kooiman J, den Exter PL, Kilicsoy I, Cannegieter SC, Eikenboom J, Huisman MV, Klok FA, Versteeg HH.

J Thromb Thrombolysis. 2015 Oct;40(3):323-30. doi: 10.1007/s11239-015-1180-z.

22.

Performance of a diagnostic algorithm based on a prediction rule, D-dimer and CT-scan for pulmonary embolism in patients with previous venous thromboembolism. A systematic review and meta-analysis.

Fabiá Valls MJ, van der Hulle T, den Exter PL, Mos IC, Huisman MV, Klok FA.

Thromb Haemost. 2015 Feb;113(2):406-13. doi: 10.1160/TH14-06-0488. Epub 2014 Nov 6. Review.

PMID:
25373512
23.

Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism.

van der Hulle T, Tan M, den Exter PL, van Roosmalen MJ, van der Meer FJ, Eikenboom J, Huisman MV, Klok FA.

Haematologica. 2015 Feb;100(2):188-93. doi: 10.3324/haematol.2014.112896. Epub 2014 Sep 26.

24.

The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.

Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S.

Blood Rev. 2014 Nov;28(6):221-6. doi: 10.1016/j.blre.2014.07.003. Epub 2014 Aug 15. Review.

PMID:
25168205
25.

Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients.

van der Hulle T, den Exter PL, Mos IC, Kamphuisen PW, Hovens MM, Kruip MJ, van Es J, Ten Cate H, Huisman MV, Klok FA.

Br J Haematol. 2014 Dec;167(5):681-6. doi: 10.1111/bjh.13090. Epub 2014 Aug 22.

PMID:
25146098
26.

The newer anticoagulants in thrombosis control in cancer patients.

den Exter PL, van der Hulle T, Klok FA, Huisman MV.

Semin Oncol. 2014 Jun;41(3):339-45. doi: 10.1053/j.seminoncol.2014.04.014. Epub 2014 Apr 24. Review.

PMID:
25023349
27.

Advances in the diagnosis and management of acute pulmonary embolism.

den Exter PL, van der Hulle T, Klok FA, Huisman MV.

Thromb Res. 2014 May;133 Suppl 2:S10-6. doi: 10.1016/S0049-3848(14)50002-3. Review.

PMID:
24862127
28.

Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism.

van der Hulle T, den Exter PL, Kooiman J, van der Hoeven JJ, Huisman MV, Klok FA.

J Thromb Haemost. 2014 Jul;12(7):1116-20. doi: 10.1111/jth.12605. Epub 2014 Jun 19.

29.

Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.

Righini M, Van Es J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, Rutschmann OT, Sanchez O, Jaffrelot M, Trinh-Duc A, Le Gall C, Moustafa F, Principe A, Van Houten AA, Ten Wolde M, Douma RA, Hazelaar G, Erkens PM, Van Kralingen KW, Grootenboers MJ, Durian MF, Cheung YW, Meyer G, Bounameaux H, Huisman MV, Kamphuisen PW, Le Gal G.

JAMA. 2014 Mar 19;311(11):1117-24. doi: 10.1001/jama.2014.2135. Erratum in: JAMA. 2014 Apr 23-30;311(16):1694.

30.

Performance of the revised Geneva score in patients with a delayed suspicion of pulmonary embolism.

den Exter PL, van den Hoven P, van der Hulle T, Mos IC, Douma RA, van Es J, Huisman MV, Klok FA.

Eur Respir J. 2014 Jun;43(6):1801-4. doi: 10.1183/09031936.00214113. Epub 2014 Feb 13. No abstract available.

31.

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis.

van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV.

J Thromb Haemost. 2014;12(3):320-8. doi: 10.1111/jth.12485. Review.

32.

Selective D-dimer testing for the diagnosis of acute deep vein thrombosis: a validation study.

van der Hulle T, Tan M, den Exter PL, Mol GC, Iglesias del Sol A, van de Ree MA, Huisman MV, Klok FA.

J Thromb Haemost. 2013 Dec;11(12):2184-6. doi: 10.1111/jth.12419. No abstract available.

33.

Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment.

Kooiman J, den Exter PL, Cannegieter SC, le Cessie S, del Toro J, Sahuquillo JC, Pedrajas JM, Huisman MV.

J Thromb Haemost. 2013 Nov;11(11):1968-76. doi: 10.1111/jth.12411.

34.

Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.

van Es J, den Exter PL, Kaptein AA, Andela CD, Erkens PM, Klok FA, Douma RA, Mos IC, Cohn DM, Kamphuisen PW, Huisman MV, Middeldorp S.

Thromb Res. 2013 Nov;132(5):500-5. doi: 10.1016/j.thromres.2013.06.016. Epub 2013 Oct 3.

PMID:
24090607
35.

Variable D-dimer thresholds for diagnosis of clinically suspected acute pulmonary embolism.

van der Hulle T, den Exter PL, Erkens PG, van Es J, Mos IC, ten Cate H, Kamphuisen PW, Hovens MM, Büller HR, Klok FA, Huisman MV.

J Thromb Haemost. 2013 Nov;11(11):1986-92. doi: 10.1111/jth.12394.

36.

Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis.

Trujillo-Santos J, den Exter PL, Gómez V, Del Castillo H, Moreno C, van der Hulle T, Huisman MV, Monreal M, Yusen RD, Jiménez D.

J Thromb Haemost. 2013 Oct;11(10):1823-32. doi: 10.1111/jth.12393. Review.

37.

New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.

den Exter PL, Kooiman J, van der Hulle T, Huisman MV.

Best Pract Res Clin Haematol. 2013 Jun;26(2):163-9. doi: 10.1016/j.beha.2013.07.004. Epub 2013 Jul 20. Review.

PMID:
23953904
38.

Long-term clinical course of acute pulmonary embolism.

den Exter PL, van der Hulle T, Lankeit M, Huisman MV, Klok FA.

Blood Rev. 2013 Jul;27(4):185-92. doi: 10.1016/j.blre.2013.06.003. Epub 2013 Jun 20. Review.

PMID:
23791363
39.

Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast-enhanced computed tomography imaging in cancer patients.

den Exter PL, Kroft LJ, van der Hulle T, Klok FA, Jiménez D, Huisman MV.

J Thromb Haemost. 2013 Aug;11(8):1620-2. doi: 10.1111/jth.12325. No abstract available.

40.

Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism.

den Exter PL, van Es J, Klok FA, Kroft LJ, Kruip MJ, Kamphuisen PW, Büller HR, Huisman MV.

Blood. 2013 Aug 15;122(7):1144-9; quiz 1329. doi: 10.1182/blood-2013-04-497545. Epub 2013 Jun 4.

41.

Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism.

den Exter PL, van Es J, Erkens PM, van Roosmalen MJ, van den Hoven P, Hovens MM, Kamphuisen PW, Klok FA, Huisman MV.

Am J Respir Crit Care Med. 2013 Jun 15;187(12):1369-73. doi: 10.1164/rccm.201212-2219OC.

PMID:
23590273
42.

Validation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer-associated thrombosis.

den Exter PL, Kooiman J, Huisman MV.

J Thromb Haemost. 2013 May;11(5):998-1000. doi: 10.1111/jth.12192. No abstract available.

43.

Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism.

Zondag W, den Exter PL, Crobach MJ, Dolsma A, Donker ML, Eijsvogel M, Faber LM, Hofstee HM, Kaasjager KA, Kruip MJ, Labots G, Melissant CF, Sikkens MS, Huisman MV; Hestia Study Investigators.

Thromb Haemost. 2013 Jan;109(1):47-52. doi: 10.1160/TH12-07-0466. Epub 2012 Nov 8.

PMID:
23138355
44.

Physicians' management approach to an incidental pulmonary embolism: an international survey.

den Exter PL, van Roosmalen MJ, van den Hoven P, Klok FA, Monreal M, Jiménez D, Huisman MV.

J Thromb Haemost. 2013 Jan;11(1):208-13. doi: 10.1111/jth.12040. No abstract available.

45.

Diagnosis of pulmonary embolism: Advances and pitfalls.

den Exter PL, Klok FA, Huisman MV.

Best Pract Res Clin Haematol. 2012 Sep;25(3):295-302. doi: 10.1016/j.beha.2012.06.002. Epub 2012 Jul 31. Review.

PMID:
22959546
46.

A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer.

den Exter PL, Gómez V, Jiménez D, Trujillo-Santos J, Muriel A, Huisman MV, Monreal M; Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Investigators.

Chest. 2013 Jan;143(1):138-145. doi: 10.1378/chest.12-0964.

PMID:
22814859
47.

Outcome of incidentally diagnosed pulmonary embolism in patients with malignancy.

den Exter PL, Jiménez D, Kroft LJ, Huisman MV.

Curr Opin Pulm Med. 2012 Sep;18(5):399-405. doi: 10.1097/MCP.0b013e3283553914. Review.

PMID:
22634737
48.

Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.

den Exter PL, Hooijer J, Dekkers OM, Huisman MV.

J Clin Oncol. 2011 Jun 10;29(17):2405-9. doi: 10.1200/JCO.2010.34.0984. Epub 2011 May 9.

PMID:
21555690
49.

Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation.

van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT.

Int J Antimicrob Agents. 2010 Dec;36(6):485-90. doi: 10.1016/j.ijantimicag.2010.05.005. Epub 2010 Jun 26. Review.

PMID:
20580533
50.

[Phyllodes tumour: a rare, rapidly growing breast tumour].

den Exter PL, Hornstra BJ, Vree R.

Ned Tijdschr Geneeskd. 2009;153:A981. Dutch.

PMID:
20015419

Supplemental Content

Loading ...
Support Center